Compound ID | 225
Class: Antivirulence agent
Spectrum of activity: | Gram-negative |
Details of activity: | Targets Vibrio cholerae flagellum; motility inhibitor of Vibrio cholerae |
Institute where first reported: | Southern Research Institute Drug Discovery Division, Birmingham, Alabama, USA |
Year first mentioned: | 2011 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|